KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ

Molecular Cell

Volumn 36, Issue 1, 2009, Pages 131-140

  Lee, Dung Fang ^a,b   Kuo, Hsu Ping ^a,b   Liu, Mo ^a,b   Chou, Chao Kai ^a,b   Xia, Weiya ^a   Du, Yi ^a,b   Shen, Jia ^a,b   Chen, Chun Te ^a,b   Huo, Longfei ^a   Hsu, Ming Chuan ^a   Li, Chia Wei ^a   Ding, Qingqing ^a   Liao, Tsai Lien ^c   Lai, Chien Chen ^d,e   Lin, Ann Chi ^c   Chang, Ya Hui ^c   Tsai, Shih Feng ^c   Li, Long Yuan ^d,f   Hung, Mien Chie ^a,b,d,f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE LOCUS; GENE LOSS; HUMAN; HUMAN CELL; MISSENSE MUTATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; CULLIN PROTEINS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MICE; MUTATION; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION;

EID: 70349970493     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2009.07.025     Document Type: Article

References (19)

1. Chari R., Lockwood W.W., Coe B.P., Chu A., Macey D., Thomson A., Davies J.J., MacAulay C., and Lam W.L. SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics 7 (2006) 324
2. Elfilali A., Lair S., Verbeke C., La Rosa P., Radvanyi F., and Barillot E. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res. 34 (2006) D613-D616
3. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
4. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13 (1999) 76-86
5. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
6. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24 (2004) 7130-7139
7. Lee D.F., and Hung M.C. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6 (2007) 3011-3014
8. Lee D.F., Kuo H.P., Chen C.T., Hsu J.M., Chou C.K., Wei Y., Sun H.L., Li L.Y., Ping B., Huang W.C., et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130 (2007) 440-455
9. Lo S.C., and Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J. Biol. Chem. 281 (2006) 37893-37903
10. Motohashi H., Katsuoka F., Engel J.D., and Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 6379-6384
11. Nioi P., and Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362 (2007) 816-821
12. Ohta T., Iijima K., Miyamoto M., Nakahara I., Tanaka H., Ohtsuji M., Suzuki T., Kobayashi A., Yokota J., Sakiyama T., et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68 (2008) 1303-1309
13. Padmanabhan B., Tong K.I., Ohta T., Nakamura Y., Scharlock M., Ohtsuji M., Kang M.I., Kobayashi A., Yokoyama S., and Yamamoto M. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21 (2006) 689-700
14. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8 (2007) 49-62
15. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., and Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135 (2008) 1358-1368
16. Singh A., Misra V., Thimmulappa R.K., Lee H., Ames S., Hoque M.O., Herman J.G., Baylin S.B., Sidransky D., Gabrielson E., et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3 (2006) e420
17. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
18. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
19. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (2004) 10941-10953